Home > Products > Biosimilars

BioSIM anti-Human PD-1/CD279 Antibody (Sintilimab Biosimilar), Research Grade

Catalog: SIM0031
Cost advantage to: SIM0054
Isotype: IgG4-kappa
Product Details Specifications Application References Related Products

Product Details

This non-therapeutic biosimilar has the same variable regions as Sintilimab (ideal for research). Sintilimab, a humanized IgG4κ mAb with S228P mutation, binds PD-1 (CD279), shows higher affinity than nivolumab/pembrolizumab, and cross-reacts with cynomolgus monkey PD-1. PD-1/PD-L1 regulates immune homeostasis; cancers exploit this pathway. Anti-PD-1 (e.g., sintilimab) transiently arrests tumor growth in responsive models.
 

Specifications

Product Name BioSIM anti-Human PD-1/CD279 Antibody (Sintilimab Biosimilar), Research Grade
Size 1mg/5mg
Isotype IgG4-kappa
Target PD-1/CD279
Other Names IBI-308, CAS: 2072873-06-2
CAS 2072873-06-2
Reactivity Human
Host Species Human
Background This non-therapeutic biosimilar has the same variable regions as Sintilimab (ideal for research). Sintilimab, a humanized IgG4κ mAb with S228P mutation, binds PD-1 (CD279), shows higher affinity than nivolumab/pembrolizumab, and cross-reacts with cynomolgus monkey PD-1. PD-1/PD-L1 regulates immune homeostasis; cancers exploit this pathway. Anti-PD-1 (e.g., sintilimab) transiently arrests tumor growth in responsive models.
Applications ELISA, FACS, Functional assay, Research in vivo
Purification Protein A/G
Storage To ensure appropriate storage, Please avoid repeated freeze thaw cycles. Keep the product at 4°C for short-term needs (1–2 weeks); Store at -20°C for up to 12 months.  For long-term storage, store at -80°C.
Shipping 2-8°C with blue ice
Concentration Lot specific, generally ≥ 5.0 mg/ml
Shelf Life 12 months from the date of receipt if stored as recommended
Formulation PBS, pH 7.4, contains no stabilizers or preservatives
Sterility 0.2 μM filtered
Endotoxin ≤ 1.0 EU/mg
Purity 99%

Application References

Related Products